000 01431 a2200397 4500
005 20250517064418.0
264 0 _c20160820
008 201608s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2015.10.056
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReperant, Leslie A
245 0 0 _aQuantifying the risk of pandemic influenza virus evolution by mutation and re-assortment.
_h[electronic resource]
260 _bVaccine
_cDec 2015
300 _a6955-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aCoinfection
_xvirology
650 0 4 _aEvolution, Molecular
650 0 4 _aHumans
650 0 4 _aImmunocompromised Host
650 0 4 _aInfluenza A virus
_xgenetics
650 0 4 _aInfluenza, Human
_xvirology
650 0 4 _aModels, Theoretical
650 0 4 _aMutation
650 0 4 _aOrthomyxoviridae Infections
_xvirology
650 0 4 _aPandemics
650 0 4 _aReassortant Viruses
_xgenetics
650 0 4 _aRisk Factors
650 0 4 _aVirus Replication
650 0 4 _aZoonoses
_xvirology
700 1 _aGrenfell, Bryan T
700 1 _aOsterhaus, Albert D M E
773 0 _tVaccine
_gvol. 33
_gno. 49
_gp. 6955-66
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2015.10.056
_zAvailable from publisher's website
999 _c25482637
_d25482637